University of Pennsylvania

ScholarlyCommons
Neuroethics Publications

Center for Neuroscience & Society

5-15-2014

Minds, Motherboards, and Money: Futurism and Realism in the
Neuroethics of BCI Technologies
Mark A. Attiah
University of Pennsylvania

Martha J. Farah
University of Pennsylvania, mfarah@psych.upenn.edu

Follow this and additional works at: https://repository.upenn.edu/neuroethics_pubs
Part of the Bioethics and Medical Ethics Commons, Neuroscience and Neurobiology Commons, and
the Neurosciences Commons

Recommended Citation
Attiah, M. A., & Farah, M. J. (2014). Minds, Motherboards, and Money: Futurism and Realism in the
Neuroethics of BCI Technologies. Frontiers in Systems Neuroscience, 8 Article 86-. http://dx.doi.org/
10.3389/fnsys.2014.00086

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/neuroethics_pubs/118
For more information, please contact repository@pobox.upenn.edu.

Minds, Motherboards, and Money: Futurism and Realism in the Neuroethics of
BCI Technologies
Abstract
From the Introduction:
Brain computer interfaces (BCIs) are systems that enable the brain to send and receive information to and
from a computer, bypassing the body's own efferent and afferent pathways. BCIs have been used in
experimental animal models to augment perception, motor control and even memory (Velliste et al., 2008;
Berger et al., 2011; Torab et al., 2011). Human BCIs include cochlear implants and a host of experimental
devices including retinal implants (Niparko et al., 2010; Klauke et al., 2011). BCI technology holds the
potential to benefit humanity greatly, but also the potential to do harm, and its ethical implications have
therefore been addressed by a number of commentators.
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INTRODUCTION
Brain computer interfaces (BCIs) are systems that enable the brain to send and
receive information to and from a computer, bypassing the body’s own efferent and afferent pathways. BCIs have
been used in experimental animal models to augment perception, motor control
and even memory (Velliste et al., 2008;
Berger et al., 2011; Torab et al., 2011).
Human BCIs include cochlear implants
and a host of experimental devices including retinal implants (Niparko et al., 2010;
Klauke et al., 2011). BCI technology
holds the potential to benefit humanity greatly, but also the potential to do
harm, and its ethical implications have
therefore been addressed by a number of
commentators.

THE PROBLEM WITH SCIENCE FICTION
Commonly addressed ethical challenges
with BCIs concern a future when the technology is used to give people superhuman abilities, or to control their thoughts
and desires. The idea of human beings
with computer-augmented brains engenders a wide range of reactions from laypersons, mostly negative (Lipsman et al.,
2009; Lebedev, 2014). There is revulsion
toward these so-called cyborgs occupying the “uncanny valley” between fellow human and robot (Mori, 1970).
Some fear being overtaken by cyborgs
with superior perceptual, cognitive and
motoric powers while others are afraid that
BCIs imposed upon us would result in
mind control. Still others foresee tremendous benefit for humanity, with BCI
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enhancements elevating individuals and
society.
Positive or negative, these images of
computer-augmented brains are as speculative as they are vivid. Therein lie two
significant challenges for ethical analysis
of BCIs. First, we have strong emotional
reactions to the prospects of humans
with cyborg brains. Second, our limited
real-world experience with BCIs deprives
our ethical analyses of a foundation
of pragmatic empirical knowledge. As
a result, our perspectives on the ethical and societal impact of BCIs are
based primarily on gut reactions, either
“the wisdom of repugnance” (as exemplified by Francis Fukuyama’s nomination of transhumanism as “The World’s
Most Dangerous Idea, 2004”) or the
blind faith that technology can fix and
improve everything (as exemplified by
the mission statement of Humanity+,
which promotes “the ethical use of technology to expand human capacities. . . [to
make them] better than well” (http://
humanityplus.org/).
In this essay, we describe an approach to
the ethical analysis of BCIs that resists the
emotional pull of futuristic scenarios without denying the importance of the questions they raise. In so doing, we address the
more prosaic ethical issues that confront
us now, which are too often overshadowed by the more sensational prospects of
cyborgs, mind control and transhumanism. Finally, we indicate pathways through
which seemingly fantastical futuristic scenarios can be more knowledgeably anticipated and addressed.
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THREE ERAS OF BCIS AND THEIR
ETHICAL CHALLENGES
As an organizing framework, we will distinguish among three different eras of BCI
development, near-term, medium-term,
and long-term, and distinguish among
the different ethical issues associated with
each.
LONG-TERM CHALLENGES

The futuristic ethical concerns already
mentioned arise in the long-term future.
We define this era as when BCIs are routinely used to augment human brains,
giving users perceptual, cognitive and
motoric abilities that may greatly exceed
those of the unenhanced, and transforming emotional life as well. At this point,
cyborgs will differ radically from unenhanced humans. One concern is that they
will view us as a different, and inferior, life
form, much as we now regard chimpanzees
(Warwick, 2003). Loss of individuality is
another long-term future scenario. If BCIs
are used for direct brain-to-brain contact,
this would enable new modes of communication but also lead to the possible
replacement of individual mental lives by
a network in which individual brains are
mere nodes (Warwick, 2003).
Thoughts, feelings and memories that
can be stored and shared as bits of data
will not degrade as readily as human brain
tissue. While other prosthetics such as artificial hips or heart valves can replace failing
bodily structures, BCIs offer the first possibility of increased longevity of a person’s
consciousness. Immortality may even be
possible (McGee and Maguire, 2007).
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These BCI scenarios lead to interesting questions about what it means to be
human. Would we be human if we could
see infrared light, memorize a phone book,
or cause others to move by willing them
to with our own mind? Would we be
human if we ceded the role of smartest
beings on earth to others, or would those
enhanced beings be humanity’s new form?
Would we be human if our minds never
operated independently from others’? If
they operated for eternity? These questions raise the more general question of
what it means to be human, and also the
question of whether being human by any
particular definition has intrinsic value.
Although these questions are age-old, they
arise with a new urgency in connection
with advanced BCIs (McGee and Maguire,
2007).
BCIs could eventually bring about tectonic societal shifts. The effects of cochlear
implants on deaf culture (Tucker, 1998)
may presage the impact of BCIs on all
aspects of human culture that are adapted
to current human capabilities rather than
the augmented, networked capabilities of
future cyborgs. Global political trends
such as the Arab Spring, attributed in
part to social networking, could be distant
harbingers of the effect of wide bandwidth
BCIs that enable the sharing of thoughts
and feelings among groups of individuals.
MEDIUM-TERM CHALLENGES

The ethical challenges of the medium term
will be largely free of the existential and
metaphysical dimensions just discussed,
such as ceding dominion of the earth to
others, merging our identities into a global
network, or questioning the meaning and
value of being human. Yet the emergence of these medium-term challenges
will depend on BCI technology advancing significantly beyond its current state
and therefore do still have a science fiction flavor. We take the defining feature of
the medium-term to be the availability of
BCI therapies for a wide range of human
afflictions.
One set of ethical issues at this point
will concern barriers to delivery of BCI
therapies. One barrier is likely to be economic. The cost of BCIs in the coming
decades is hard to predict, as is future
societal support for universal access, but
we can anticipate some degree of inequity
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in access to BCIs. Patient acceptance
of implants, in particular the bioethicists’ “yuck factor” (Niemelä, 2011) may
also prevent or slow delivery of BCI
therapies.
Another issue with a degree of bioethical precedent concerns control of the
BCI (Jebari and Hansson, 2013). Therapies
vary in how much control patients have.
How much adjustment or programming of
a BCI by the patient will be feasible, and
with what risks and benefits? An aspect of
control with much less precedent concerns
the possibility of BCI hacking, that is, the
possibility that a third party, unbeknownst
to patient and healthcare provider, would
deliver inputs to a patient’s brain or
read brain states (Denning et al., 2009).
Although safeguards against such interventions could of course be designed into
any system, experience with current information technology shows that no system
can ever be made entirely invulnerable to
such attacks. This raises the dire prospect
of hacking into systems controlling human
thought, feeling and behavior.
Finally, as BCIs are adopted more
widely for therapeutic use, enhancement
uses will likely follow. The ethics of
enhancement is a well-explored area in
bioethics and neuroethics more specifically (Parens, 2000; Farah et al., 2014).
However, compared to the effects of drugs,
which only modulate function within
existing brain networks, the addition of
new sensory, action and computational
devices has the potential to more radically
enhance human capabilities.
The transition from therapy to
enhancement is evident in many areas of
medicine: from neuropsychiatry, where
attention-boosting drugs are used by
college students to enhance their focus
and improve their grades (Sussman
et al., 2006), to plastic surgery, where
techniques developed to reconstruct
injured faces are now commonly used
to enhance the attractiveness of the uninjured. Therapeutic implantation of BCIs
for only mildly impaired individuals could
provide a bridge between therapy and
enhancement uses of BCI. Another pathway along which BCIs could transition
from therapy to enhancement is by the
addition of enhancing BCIs for someone
who is already undergoing therapeutic implantation for a serious disorder,
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for example increasing the range of
wavelengths perceived by someone with
impaired vision.
NEAR-TERM CHALLENGES

Compared with the challenges awaiting us
in the medium and long-term, which are
currently speculative, we are now faced
with a set of ethical challenges that are
clear and present. How we respond to
these challenges will determine the path
we take to the medium- and long-term
challenges of BCIs. One set of ethical
challenges concerns clinical trials—how
trials are conducted and which indications are pursued. Economic considerations of course shape these decisions, and
the ethical issue is how these considerations will be balanced by other considerations. Will BCIs be developed only for
the most profitable applications, leaving
numerous “orphan” medical conditions
unaddressed? How will an emphasis on
profitability shape the future of BCI technology, by advancing technology for certain applications over others?
A related set of immediate challenges
concerns ownership of products during
research and development. The finances
of pharmaceutical research and development has been identified as an impediment to discovery and innovation (Cohen,
2005), as well as a disincentive for scientific
objectivity and transparency (Goldacre,
2013). Given the extensive collaboration
of academic and other publicly funded
researchers with privately held device
manufacturers, how should we design
intellectual property agreements, clinical
trials and regulation to maximize innovation and patient benefit?

APPROACHING THE FUTURE STEP BY
STEP
We cannot help but approach the future
step by step. In contrast, ethical analyses sometimes jump ahead. This is motivated by the commendable desire to
anticipate, and therefore more effectively
address, the ethical issues of the future. But
this long-term ethical forecasting can be
counterproductive. One reason is that it
takes our attention away from the vitally
important, if more mundane, ethical
issues of today. Pondering what it means
to be human may be more interesting
than projecting research and development

May 2014 | Volume 8 | Article 86 | 2

Attiah and Farah

Minds, motherboards, and money

Table 1 | Three eras of BCIs and their corresponding ethical challenges.
Time period Characteristics

Ethical challenges

Long-term

Transhuman cyborgs’ treatment of humans as
inferior and inconsequential

Extensive enhancement of
human brains with BCIs

Vulnerability of those with BCIs to thought control
and mind-reading
Loss of individuality to a merged group mind
Immortality of thoughts, memories and whole
minds
Medium-term Routine use of BCIs as therapy

Cost of BCIs as an obstacle for needy patients
Discomfort or disgust with implants as an obstacle
for patients
Question of who controls operation of patients’
BCIs
Security of BCIs against hacking
Acceptance of BCIs for enhancement of normal
function

Near-term

Use of BCIs in a translational
research setting

Conduct of clinical trials
Developing BCI systems that maximize benefit as
opposed to profit
Ownership of intellectual property as an
impediment or incentive to biomedical advances
The influence of funding sources on research
priorities

output under different intellectual property regimes. However, there is only one
opportunity to get current decisions right,
and that is now. Another reason is that
bioethical decisions depend not only on
values and principles, but also on the
facts of the matter, which we have limited ability to anticipate in the distant
future. Only as we live through each of
the eras summarized in Table 1 will we be
positioned to predict the likely empirical
constraints on the ethical decisions of the
next era.
For example, how current BCI work
is financed, who controls intellectual
property and so forth, will set our course
toward the next set of issues, the decisions
on what gets commercially developed,
how patients get access, and what kind
of enhancements are available. Then,
depending on our experience with whatever mix of technologies is developed in
that medium-term period—which sensory, motor and cognitive systems can
be effectively augmented for therapy and
enhancement, what unanticipated benefits
and harms emerge—we will have a much
better platform from which to foresee
and address the currently imponderable
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long-term ethical challenges of BCIs and
transhumanism.
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